Euro-Med Laboratories Phil., Inc. Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2019
May 06, 2019 at 12:47 am EDT
Share
Euro-Med Laboratories Phil., Inc. announced unaudited earnings results for the first quarter ended March 31, 2019. For the quarter, the company reported net sales of PHP 874,046,890 against PHP 803,677,877 a year ago. Total profit was PHP 341,772,673 against PHP 306,065,151 a year ago. Net income was PHP 60,075,809 against PHP 57,068,496 a year ago. Basic and diluted earnings per share was PHP 0.01 against PHP 0.01 a year ago.
Euro-Med Laboratories Phil., Inc. is a Philippines-based company, which is engaged in the manufacturing of pharmaceutical products, such as large and small-volume parenteral and other solutions, inhalation, irrigation, and dialysis. It also manufactures sterile water for injection, and other solutions, such as ophthalmic, inhalation, irrigation and dialysis. The Company's segments include manufacturing pharmaceutical products, providing health and other care services, and development and operation of quick service restaurants. Its subsidiaries include Hemotek Renal Center, Inc. (Hemotek), and CafeFrance Corp (CafeFrance). Hemotek provides renal and other healthcare services and is engaged as a dialysis center. CafeFrance is engaged in the development and operation of quick service restaurant (QSR). CafeFrance is engaged in operating restaurants, bakeries, food services, catering, food production and other related services incidental thereto.
EURO-MED LABORATORIES PHIL., INC. 
